Deregulated MYC expression induces dependence upon AMPK-related kinase 5

Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Nature (Impact Factor: 41.46). 03/2012; 483(7391):608-12. DOI: 10.1038/nature10927
Source: PubMed


Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumours, yet strategies to exploit this for a rational tumour therapy are scarce. MYC promotes cell growth and proliferation, and alters cellular metabolism to enhance the provision of precursors for phospholipids and cellular macromolecules. Here we show in human and murine cell lines that oncogenic levels of MYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival. ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signalling pathway. ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metabolism. Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence. Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumour cells that express deregulated MYC.

Download full-text


Available from: Daniel J Murphy,
  • Source
    • "Proteome analysis was performed as described by us previously (Liu et al., 2012). Briefly: to achieve quantitative proteome data, a ''heavy'' proteome reference was spiked in equal amounts in every sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graphical Abstract Highlights d The metabolic profile of embryonic stem cell changes within hours of differentiation d Glycolytic production of acetyl-CoA promotes histone acetylation during pluripotency d Glycolysis inhibition leads to deacetylation and differentiation of pluripotent cells d Pharmacologic modulation of acetyl-CoA regulates pluripotency
    Cell metabolism 03/2015; · 17.57 Impact Factor
  • Source
    • "Surprisingly, we observed that 2DG does not directly block glycolysis but rather interferes with phosphate and thus ATP metabolism. In summary, we show that the pSIRM approach facilitates the identification of metabolic dysregulation directly, without the need to separately calculate metabolic fluxes [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Cellular metabolism is highly dynamic and continuously adjusts to the physiological program of the cell. The regulation of metabolism appears at all biological levels: (post-) transcriptional, (post-) translational, and allosteric. This regulatory information is expressed in the metabolome, but in a complex manner. To decode such complex information, new methods are needed in order to facilitate dynamic metabolic characterization at high resolution. Results Here, we describe pulsed stable isotope-resolved metabolomics (pSIRM) as a tool for the dynamic metabolic characterization of cellular metabolism. We have adapted gas chromatography-coupled mass spectrometric methods for metabolomic profiling and stable isotope-resolved metabolomics. In addition, we have improved robustness and reproducibility and implemented a strategy for the absolute quantification of metabolites. Conclusions By way of examples, we have applied this methodology to characterize central carbon metabolism of a panel of cancer cell lines and to determine the mode of metabolic inhibition of glycolytic inhibitors in times ranging from minutes to hours. Using pSIRM, we observed that 2-deoxyglucose is a metabolic inhibitor, but does not directly act on the glycolytic cascade.
    06/2014; 2(1):9. DOI:10.1186/2049-3002-2-9
  • Source
    • "Wu has reported that treatment of bovine aortic endothelial cells (BAECs) with OA-NO2 induced a significant increase in AMPKThr172 phosphorylation and AMPK activity [36]. Recent reports have shown that oncogenic Ras, MYC and Pten deletion activates AMPK and that this activation stimulates cell proliferation [31], [37]. We hypothesise that the intracellular stresses or the oncogene induced by OA treatment in high metastatic cancer cells contribute to the activation of AMPK. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastric cancer and breast cancer have a clear tendency toward metastasis and invasion to the microenvironment predominantly composed of adipocytes. Oleic acid is an abundant monounsaturated fatty acid that releases from adipocytes and impinges on different energy metabolism responses. The effect and underlying mechanisms of oleic acid on highly metastatic cancer cells are not completely understood. We reported that AMP-activated protein kinase (AMPK) was obviously activated in highly aggressive carcinoma cell lines treated by oleic acid, including gastric carcinoma HGC-27 and breast carcinoma MDA-MB-231 cell lines. AMPK enhanced the rates of fatty acid oxidation and ATP production and thus significantly promoted cancer growth and migration under serum deprivation. Inactivation of AMPK attenuated these activities of oleic acid. Oleic acid inhibited cancer cell growth and survival in low metastatic carcinoma cells, such as gastric carcinoma SGC7901 and breast carcinoma MCF-7 cell lines. Pharmacological activation of AMPK rescued the cell viability by maintained ATP levels by increasing fatty acid β-oxidation. These results indicate that highly metastatic carcinoma cells could consume oleic acid to maintain malignancy in an AMPK-dependent manner. Our findings demonstrate the important contribution of fatty acid oxidation to cancer cell function.
    PLoS ONE 05/2014; 9(5):e97330. DOI:10.1371/journal.pone.0097330 · 3.23 Impact Factor
Show more